Skip to content
Kalpvruksh Markets
Offline Log in

AJANTPHARMNSEOffline

AJANTA PHARMA · INE031B01049 · Mid Cap · #241
3,282.10−34.60 (−1.04%)last close · 05 Nov 2026
Prev close
3,316.70
Open
—
High
—
Low
—
Volume
—
Mkt cap (6-mo avg)
₹36,666 cr
52-week range · to 05 Nov 20262,458.13,718.2

Loading minute bars…

NSE 1-minute bars from our CandleApi gateway (history from 21 Jul 2026); longer timeframes are built from them. Prices not adjusted for corporate actions.

AJANTPHARM is 12% below its 52-week high, above its 200-day average, behind Healthcare by 5.4 pts over 3 months — a Mid Cap company, #241 by market cap.NSE prices to 05 Nov 2026 · a description of the data, not advice

Overview

What the data says, line by line

A description, never a buy or sell word · tap a line for its detail

  • above its 200-day average · below its 20 / 50-day averages · 12% below its 52-week high
  • behind its industry by 5.4 pts over 3 months · rank 33 of 44 in Healthcare · −2.4% vs Nifty 500
  • traded value 4.5× usual · delivery 57% vs 53% usual
  • FPI −0.1 pp · DII +0.1 pp · MF schemes in Sept 2026: 79 bought, 26 cut · promoter pledge 20.6% · quarter ended 2026-09-30
  • Sept 2026 quarter: profit +49% year on year · revenue +33%
  • nothing scheduled or restricting

How big is it?

six-month average market cap

Market capitalisation
₹36,666 cr
Rank
#241
Cap band
Mid Cap
Nearest cut-off — Mid / Small
+7.24% from ₹34,190 cr
Clear of the cut-off

Our own six-month average, computed the way AMFI computes it; the published classification is on the market cap page.

Did buyers take delivery?

latest session · 2026-11-05

vs its own normal
1.8×
median 68,422
Delivered
1,22,157
Of volume
68%

Price & trend

Returns

to 05 Nov 2026

PeriodStockvs Nifty 500vs its industry
1 week−5.1%−10.4 pts—
1 month−8.2%−12.2 pts−11.6 pts
3 months−4.5%−2.4 pts−5.4 pts
6 months+6.0%+5.6 pts−4.4 pts
1 year+33.0%+36.5 pts—

Industry: Healthcare (Nifty 500 classification) · rank 33 of 44 over 3 months. Points = the stock’s return minus the benchmark’s. Prices adjusted for splits and bonuses.

Averages & movement

vs 20-day average
−2.2%
below
vs 50-day average
−5.3%
below
vs 200-day average
+3.3%
above
ATR (14)
3.7%
typical daily range
Volatility
30%
1 month, annualised
Beta
0.47
vs Nifty 500, 1 year
Traded value
4.5×
vs usual
Delivery
57%
usual 53%
From the 52-week high
−11.7%
place in range 65% (0 = at the low)

Ownership

Who owns the company

% of all shares, by quarter

GroupDec 25Mar 26Jun 26Sep 26
Promoters66.3%66.3%63.5% −2.863.5%
FPI8.0%8.3% +0.37.7% −0.67.6% −0.1
Mutual funds15.5%15.2% −0.318.1% +2.917.9% −0.2
Other DII3.1%3.1% +0.13.7% +0.64.0% +0.3
Individuals6.4%6.3% −0.16.3% −0.16.2%
Others0.8%0.8%0.8%0.8%

From the company’s quarterly shareholding pattern. Changes in percentage points against the quarter before. No quarters are on record between Sep 2022 and Jun 2025.

Promoter pledge

Sep 26

Of promoters’ holding
20.6%
Of all shares
13.1%
Jun 25 14.1%Sep 25 15.3%Dec 25 17.3%Mar 26 17.9%Jun 26 22.5%Sep 26 20.6%

Holders

Sep 26

All shareholders
61,923
Individuals
57,467

Indian passive funds’ stake

2026-06-30

Of free float
0.97%
Of all shares
0.36%
Schemes
76
Days to unwind
2.6
at 100% of volume

4,43,634 shares held by Indian passive mutual-fund schemes. A floor, not the total — foreign ETFs, insurance and EPFO are not counted.

Which funds bought and sold

mutual funds · quarter ended 2026-06-30

Funds holding
193
76 index · 117 active
Bought more
81
Sold some
33
FundSharesChangeDid
Kotak Large & Mid Cap Fund(G)Active+4,85,144+97.0%bought
Union Flexi Cap Fund-Reg(G)Active+51,890+81.0%bought
Edelweiss Mid Cap Fund-Reg(G)Active+1,86,303+47.1%bought
Bandhan Flexi Cap Fund-Reg(G)Active−91,604−42.3%sold
Bandhan Multi Asset Allocation Fund-Reg(G)Active−12,618−25.2%sold
Tata India Pharma & Healthcare Fund-Reg(G)Active−21,374−23.9%sold

Ranked by how much each fund changed its own position, not by size of trade. Every fund here still holds the company — one that sold out entirely leaves no record to find.

Mutual-fund schemes, month by month

fund houses’ own monthly portfolios

MonthSchemesBought newAddedCutSold outShares heldValue
Sep 26167673215−0.4%₹6,137 cr
Aug 26166864256+0.7%₹6,130 cr
Jul 26164842454+0.1%₹5,858 cr
Jun 261601648302+9.2%₹5,778 cr
May 26146647190+0.8%₹4,529 cr
Apr 26140449172−1.3%₹4,332 cr

Each month against the one before, counting only the fund houses that reported both (45 houses in Sep 26); a split or bonus is divided out first. “Partial” = fewer than five houses reported yet.

Fund ownership is a quarterly disclosure and counts Indian passive schemes only.

Results

Results

Events & filings

Insider trades

SEBI PIT disclosures filed with NSE

Promoter group
No market buy or sell
Directors & KMP
No market buy or sell
Others
No market buy or sell
Latest 24 of 90 disclosures
0 selected
09 Jun 2026RAVI P AGRAWAL, TRUSTEE RAVI AGRAWAL TRUSTPromoterSell34,50,000₹1,024 cr0.10%Market Sale
02 Jun 2026AAYUSH M AGRAWAL, TRUSTEE AAYUSH AGRAWAL TRUSTPromoterPledge28,55,925₹833 cr0.11%Pledge Creation
02 Jun 2026GABS INVESTMENTS PVT LTDPromoter GroupPledge27,70,000₹808 cr0.10%Pledge Creation
13 Aug 2024AAYUSH M AGRAWAL, TRUSTEE AAYUSH AGRAWAL TRUSTPromotersPledge17₹53,99311.30%Revokation of Pledge
13 Aug 2024AAYUSH M AGRAWAL, TRUSTEE AAYUSH AGRAWAL TRUSTPromotersPledge1,69,983₹53.99 cr11.30%Revokation of Pledge
07 Aug 2024AAYUSH M AGRAWAL, TRUSTEE AAYUSH AGRAWAL TRUSTPromotersPledge9,000₹2.64 cr11.30%Revokation of Pledge
26 Jun 2024Ravi Agrawal, Trustee Ravi Agrawal TrustPromotersPledge4,50,000₹104 cr12.90%Pledge Creation
19 Jun 2024AAYUSH M AGRAWAL, TRUSTEE AAYUSH AGRAWAL TRUSTPromotersSell13,341₹3.7 cr11.21%Others
19 Jun 2024AAYUSH M AGRAWAL, TRUSTEE AAYUSH AGRAWAL TRUSTPromotersSell2,341₹0.65 cr11.22%Others
19 Jun 2024AAYUSH M AGRAWAL, TRUSTEE AAYUSH AGRAWAL TRUSTPromotersSell33,736₹9.34 cr11.22%Others
19 Jun 2024AAYUSH M AGRAWAL, TRUSTEE AAYUSH AGRAWAL TRUSTPromotersSell75,322₹20.86 cr11.25%Others
19 Jun 2024RAVI P AGRAWAL, TRUSTEE RAVI AGRAWAL TRUSTPromotersSell1,10,037₹30.48 cr12.93%Others
19 Jun 2024RAJESH M AGRAWAL, TRUSTEE RAJESH AGRAWAL TRUSTPromotersSell63,012₹17.45 cr14.37%Others
19 Jun 2024RAJESH M AGRAWAL, TRUSTEE RAJESH AGRAWAL TRUSTPromotersSell31,947₹8.85 cr14.41%Others
19 Jun 2024RAJESH M AGRAWAL, TRUSTEE RAJESH AGRAWAL TRUSTPromotersSell59,932₹16.6 cr14.43%Others

Sums count buys and sells of equity (market and off-market); pledges are listed but not summed. From NSE’s filings: the archive to 2 May 2026, its XBRL filings since (NSE circular NSE/CML/2026/12). A filing describes what was done, not why.

Disclosures & deals

last six months · NSE filings

  • Board outcome
    Ajanta Pharma Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
    30 Oct 2026
  • Board outcome
    Ajanta Pharma Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
    30 Jul 2026
  • Board outcome
    Outcome of Board Meeting-XBRL AJANTA PHARMA LIMITED has informed the Exchange regarding Outcome of Board Meeting held on 30-Jul-2026 for Dividend
    30 Jul 2026
  • Bulk deal: BUY
    21,02,291 at ₹2,968 — KOTAK MAHINDRA MUTUAL FUND
    09 Jun 2026
  • Bulk deal: SELL
    34,50,000 at ₹2,968 — RAVI AGRAWAL TRUST
    09 Jun 2026
  • Block deal: BUY
    13,47,709 at ₹2,968 — ADITYA BIRLA SUN LIFE MUTUAL FUND
    09 Jun 2026
  • Block deal: BUY
    21,02,291 at ₹2,968 — KOTAK MAHINDRA MUTUAL FUND
    09 Jun 2026

Latest shown; 8 in six months on all disclosures.

AJANTPHARM: only ratings, pledges, insider and takeover disclosures, buybacks, schemes, board outcomes and deals are listed. All deals.

Corporate actions

full published history

0 selected
EarlierDividend₹32Interim05 Aug 202605 Aug 2026
EarlierDividend₹28Interim10 Nov 202510 Nov 2025
EarlierDividend₹28Interim06 Nov 202406 Nov 2024
EarlierDividend₹26Interim08 Feb 202408 Feb 2024
EarlierDividend₹15Special04 Aug 202304 Aug 2023
EarlierDividend₹10Interim04 Aug 202304 Aug 2023
EarlierDividend₹7Interim11 Nov 202214 Nov 2022
EarlierBonus1:2—22 Jun 202223 Jun 2022
EarlierDividend₹9.5Interim09 Nov 202110 Nov 2021
EarlierBonus1:2—17 Sept 201318 Sept 2013

10 shown. A falling price on an ex-date is not a loss: a dividend leaves the share as cash and a bonus multiplies the shares held.

Market capitalisation is our own six-month average, computed the way AMFI computes it; the published classification is on the market cap page. Fund ownership is a quarterly disclosure and counts Indian passive schemes only. Nothing here is advice, a recommendation, or a view on the company.